Veritas In Silico Inc. (TYO:130A)
Japan · Delayed Price · Currency is JPY 426.00
-4.00 (-0.93%)
Aug 27, 2026, 3:30 PM JST
Veritas In Silico Market Cap
Veritas In Silico has a market cap or net worth of 2.79 billion as of August 26, 2026. Its market cap has decreased by -40.61% in one year.
Market Cap
2.79B
Enterprise Value
1.36B
Revenue
84.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
426.00
ChartMarket Cap Chart
Since February 8, 2024, Veritas In Silico's market cap has decreased from 15.76B to 2.79B, a decrease of -82.30%. That is a compound annual growth rate of -49.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 2.79B | -10.42% |
| Dec 30, 2025 | 3.11B | -45.58% |
| Dec 30, 2024 | 5.72B | -63.69% |
| Feb 8, 2024 | 15.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| D. Western Therapeutics Institute | 5.12B |
| TMS Co., Ltd. | 4.98B |
| J-Pharma | 4.93B |
| Ribomic | 4.69B |
| Kohjin Bio | 4.34B |
| Transgenic Group | 4.20B |
| Kringle Pharma | 3.66B |
| Human Metabolome Technologies | 3.59B |